Filing Details
- Accession Number:
- 0001104659-21-087298
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-06-30 12:28:12
- Reporting Period:
- 2021-06-15
- Accepted Time:
- 2021-06-30 12:28:12
- Original Submission Date:
- 2021-06-17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1613859 | Pra Health Sciences Inc. | PRAH | Services-Commercial Physical & Biological Research (8731) | 463640387 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1738327 | J. Michael Bonello | C/O Pra Health Sciences, Inc 4130 Parklake Avenue, Suite 400 Raleigh NC 27612 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-06-16 | 6,589 | $166.43 | 5,275 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-06-16 | 600 | $167.47 | 4,675 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-06-16 | 195 | $168.19 | 4,480 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.07 to $166.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3) and (4) of this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.11 to $167.96, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.11 to $168.26, inclusive.
- The number of shares reported in Column 5 reflects the number of shares beneficially owned by the reporting person as of the filing date of this Form 4, which reflects the transactions reported on the Form 4 filed by the reporting person on June 21, 2021.
Billionaire Hedge Funds
